Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Q4 2020 newsletter was released Feb 1, 2021
View:
Post by floatinketucky on Jan 23, 2022 12:25pm

Q4 2020 newsletter was released Feb 1, 2021

FEB 1 2021 Was about 32  days after q42020 data collection time period.  

Theralase® Announces Leadership Reorganization
Toronto, Ontario – November 15, 2021


Perhaps this new Reorganization will include consistant reporting on the Q4 Quarterly for this year as well.   People might just have to say the new managment team got it out timley. 

  Theralase Releases Quarterly Newsletter Toronto, Ontario – February 01, 2021, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical...

Comment by floatinketucky on Jan 23, 2022 1:40pm
So if they released on Feb 1st for q4 updates the qr update would inclued time from Nov 29th forward to Dec 31.   Right?? That would bring the Newsletter proper and current. 
Comment by floatinketucky on Jan 23, 2022 1:52pm
Then maybe some HC guy or his cometitor might say them new players are playing on time.  I cant remembr the two other reps at the meeting...
Comment by 99942Apophis on Jan 23, 2022 2:16pm
floatinketucky wrote So if they released on Feb 1st for q4 updates the qr update would inclued time from Nov 29th forward to Dec 31.   Right?? That would bring the Newsletter proper and current.  Hi floatinketucky its only for the financial period for the 4th quarter or year end that they must stick to December 31. If they release the Newsletter same as last year for February ...more  
Comment by floatinketucky on Jan 23, 2022 2:31pm
Lets go with 20 to 25 Operational Highlights:  FDA Fast Track. On November 23, 2020, the FDA granted Theralase® Fast Track Designation (“FTD”) for Study II.  As a Fast Track designee, Theralase® will have access to early and frequent communications with the FDA to discuss Theralase’s development plans and ensure timely collection of the appropriate clinical ...more  
Comment by floatinketucky on Jan 23, 2022 2:38pm
$TLTFF  #Accelerated Approval (“AA”), Break Through Designation (“BTD”) and/or Priority Review,
Comment by winr88 on Jan 23, 2022 3:13pm
Hi 99942Apophis I more than doubled my TLT holdings on Friday because I want to be ready for an early newsletter release. If an early release does not occur a month is not a long time. It is however if I miss news that could drive the SP upward. 
Comment by 99942Apophis on Jan 23, 2022 3:37pm
winr88 wrote Hi 99942Apophis I more than doubled my TLT holdings on Friday because I want to be ready for an early newsletter release. If an early release does not occur a month is not a long time. It is however if I miss news that could drive the SP upward.  Hi winr88 good man, you always seem to get in under the wire. Yes could be a week or a month haha or both. 
Comment by floatinketucky on Jan 24, 2022 5:55pm
Comment by pantono1 on Jan 24, 2022 2:25am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250